Tg Therapeutics (TGTX) Interest Expenses (2011 - 2026)

Tg Therapeutics' Interest Expenses history runs 15 years deep, the most recent figure standing at $7.7 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 13.45% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $27.6 million (down 3.46% YoY), while the FY2025 annual figure was $26.7 million, up 11.23% from the prior year.
• Interest Expenses was $7.7 million for Q1 2026 at Tg Therapeutics, up from $6.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $10.8 million in Q3 2024 to a low of $1.6 million in Q3 2022.
• Historically, Interest Expenses has averaged $4.8 million across 5 years, with a median of $3.7 million in 2023.
• Biggest YoY gain for Interest Expenses was 195.32% in 2025; the steepest drop was 37.95% in 2025.
• A 5-year view of Interest Expenses shows it stood at $2.9 million in 2022, then declined by 15.06% to $2.4 million in 2023, then surged by 190.46% to $7.1 million in 2024, then decreased by 7.48% to $6.5 million in 2025, then climbed by 17.34% to $7.7 million in 2026.
• The last three Interest Expenses figures came in at $7.7 million (Q1 2026), $6.5 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.